Archive

Author: Leen Alblaihed

Hemophilia: For the Love of Bleeding

As EM physicians, we are taught how to manage and treat many serious and life threatening conditions, most of them we know like the back of our hands, and some we look up on shift. The most important things to ...

Read More
Hematology and Oncology

The DIFOCCULT Trial: Time to Change from STEMI/NSTEMI to OMI/NOMI?

Background: Prior to the discovery of thrombolytics, clinicians could only observe their patients completing their myocardial infarctions and then classify them according to whether their subsequent ECGs developed Q waves. When trials showed a clear survival benefit with thrombolytics (especially ...

Read More
Cardiovascular

The LOCO2 Trial: Liberal or Conservative Oxygen Therapy for Acute Respiratory Distress Syndrome

Background: In patients with acute respiratory distress syndrome (ARDS) the National Heart, Lung, and Blood Institute ARDS clinical trials network recommends a target partial pressure of arterial oxygen (Pao2) between 55 and 80 mmHg. Goals of arterial oxygenation are not based ...

Read More
Thoracic and Respiratory

Sponsored